Coronavirus-related hospital admissions are rising again in the United States, with older adults accounting for a growing share of US deaths and fewer than...
Real-world data from patient-reported outcomes (PRO) suggest that axicabtagene ciloleucel (axi-cel; Yescarta) is associated with a temporary worsening of quality of life (QOL) with...